Results 311 to 320 of about 546,275 (335)
Some of the next articles are maybe not open access.
Diphenylhydantoin Gingival Hyperplasia
Archives of Pediatrics & Adolescent Medicine, 1969DIPHENYLHYDANTOIN (Dilantin) sodium was synthesized in 1908 by Biltz1and introduced as an antiepileptic agent in 1938 by Merritt and Putnam.2Extensive subsequent use of this drug has confirmed its efficacy in controlling epileptic seizures, particularly major motor (grand mal) convulsions.
H L, Livingston, S, Livingston
openaire +3 more sources
Congenital Adrenal Hyperplasia
Clinical Biochemistry, 1973The enzyme defects of steroidogenesis appear to be monogenic disorders. The clinical heterogeneity of these disorders suggests allelic variations at the loci for these disorders, as has been reported for other gentic inborn errors. When the genes for these enzymes are cloned and sequenced, the final proof of allelism will be obtained.
M I, New, L S, Levine
openaire +4 more sources
Cutaneous Lymphoid Hyperplasias
Seminars in Cutaneous Medicine and Surgery, 2000Benign hyperplastic lymphoid infiltrates of the skin (pseudolymphoma, older term) simulate lymphoma clinically and histologically. They can be divided into B-cell predominant (typical cutaneous lymphoid hyperplasia (CLH), angiolymphoid hyperplasia, Kimura's disease, and Castleman's disease) and T-cell predominant (T-cell CLH, lymphomatoid contact ...
A C, Gilliam, G S, Wood
openaire +2 more sources
Pathology - Research and Practice, 1988
The morphologic study of a large number of human pituitary tissues provided conclusive evidence that hyperplasia of various adenohypophysial cell types exists. These rare lesions may serve as the underlying cause of pituitary hypersecretory syndromes.
openaire +2 more sources
The morphologic study of a large number of human pituitary tissues provided conclusive evidence that hyperplasia of various adenohypophysial cell types exists. These rare lesions may serve as the underlying cause of pituitary hypersecretory syndromes.
openaire +2 more sources